GT Medical Technologies Names Dr. Michael A. Garcia
as Chief Medical Officer
GT Medical Technologies Announces 2022 GammaTile® ELITE Brain Tumor Centers
GT Medical Technologies, Inc. announced its latest roster of ELITE Brain Tumor Centers that have received the distinction for completing 10 or more GammaTile Therapy procedures in 2022.
Arizona Center for Cancer Care Marks an Extraordinary Milestone
Arizona Center for Cancer Care (AZCCC) today announced its 100th patient treated with GammaTile® Therapy, a Surgically Targeted Radiation Therapy (STaRT) for brain tumors.
GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile® Therapy for Newly Diagnosed Glioblastoma Brain Tumors
Enrolling Newly Diagnosed Patients with Glioblastoma in the GESTALT Clinical Trial